香港正在为即将于2026年第四季度启动的“药物监管中心”招募人才，旨在获取世界卫生组织认可，并争取在2030年前实现药物自主审批。
香港正在全球范围内寻觅人才，为即将成立的药物监管中心配备人手。该机构计划于今年第四季度投入运作。医务卫生局局长卢宠茂表示，政府正与内地有关部门商讨，旨在为该中心取得世界卫生组织的认可。此举被视为确立该监管机构成为国际认可药物首要评估者的关键步骤。过去，香港仅在两个或以上的其他经济体或司法管辖区确认药物的质量、安全及成效标准后，才会批准药物注册。卢宠茂指出，这种做法导致香港无法第一时间获得先进药物。此次改革符合国家政策及粤港澳大湾区的发展战略。7月1日是香港回归中国29周年纪念日。
Hong Kong's Secretary for Health Lo Chung-mau affirmed the city's commitment to helping mainland China's medical and health standards 'go global' at the opening of the 15th China Chest Pain Centres Congress. He hailed the event as of 'great significance' as the first national Chinese medical conference hosted in the city.
由 AI 报道
Former Hong Kong leader Leung Chun-ying launched a traditional Chinese medicine (TCM) trading platform on Thursday in Nansha, Guangdong province, to connect mainland Chinese manufacturers with international markets using Hong Kong's testing and certification systems. The Shouchuang platform, established under the TCM All-sector Hong Kong Centre founded by Leung in 2022, aims to promote centralisation, standardisation, marketisation and transparency in trade.
Hong Kong's Innovation, Technology and Industry Bureau aims to secure half of the HK$440 million (US$56.2 million) investment for a planned national innovation centre from the private sector. The centre in Yuen Long InnoPark sets ambitious targets to become self-sufficient in three years and profitable by its fifth year. It will be the first national manufacturing innovation centre outside mainland China, advancing artificial intelligence development.
由 AI 报道
Xia Baolong, director of the Hong Kong and Macau Affairs Office, has recognised local efforts on innovation projects and urged the city to seize national opportunities.